From First Class to Third Class: Recent Upheaval in Antiarrhythmic Therapy-Lessons from Clinical Trials
- 1 August 1996
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (4) , 28-33
- https://doi.org/10.1016/s0002-9149(96)00450-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- 901–41 Preliminary Mortality Results from the Survival with Oral D-Sotalol (SWORD) TrialJournal of the American College of Cardiology, 1995
- A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular TachyarrhythmiasNew England Journal of Medicine, 1993
- A Comparison of Electrophysiologic Testing with Holter Monitoring to Predict Antiarrhythmic-Drug Efficacy for Ventricular TachyarrhythmiasNew England Journal of Medicine, 1993
- Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)The American Journal of Cardiology, 1993
- Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot studyJournal of the American College of Cardiology, 1992
- Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial InfarctionNew England Journal of Medicine, 1992
- The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.Circulation, 1991
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel antiarrhythmic study of infarct survival (BASIS)Journal of the American College of Cardiology, 1990
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989